VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 129–229 | Fragment:SECOND EXTRACELLULAR IMMUNOGLOBULIN-LIKE DOMAIN | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 5.7;300 K;Ionic strength (raw mmCIF value) 150mM;Pressure AMBIENT NMR sample composition:1MM FLT-1(DOMAIN2) U-15N,13C; PHOSPHATE BUFFERED SALINE, PH 5.7; 50UM EDTA; 100UM NAN3; 50UM DSS NMR sample composition:1MM FLT-1(DOMAIN2) U-15N; PHOSPHATE BUFFERED SALINE, PH 5.7; 50UM EDTA; 100UM NAN3; 50UM DSS NMR sample composition:1MM FLT-1(DOMAIN2) 15% 13C; PHOSPHATE BUFFERED SALINE, PH 5.7; 50UM EDTA; 100UM NAN3; 50UM DSS | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1QSZ | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1FLT VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR Deposited 1997-11-20 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain X
132–226(95 aa)
Fragment:SECOND EXTRACELLULAR IGG LIKE DOMAIN, RESIDUES 129 - 229
Chain Y
132–226(95 aa)
Fragment:SECOND EXTRACELLULAR IGG LIKE DOMAIN, RESIDUES 129 - 229
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.5
|
Resolution 1.70 Å R-free 0.261 |
| 1FLT VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR Deposited 1997-11-20 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain X
132–226(95 aa)
Fragment:SECOND EXTRACELLULAR IGG LIKE DOMAIN, RESIDUES 129 - 229
Chain Y
132–226(95 aa)
Fragment:SECOND EXTRACELLULAR IGG LIKE DOMAIN, RESIDUES 129 - 229
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.5
|
Resolution 1.70 Å R-free 0.261 |
| 1QSV THE VEGF-BINDING DOMAIN OF FLT-1, 20 NMR STRUCTURES Deposited 1999-06-23 | Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
129–229(101 aa)
Fragment:SECOND EXTRACELLULAR IMMUNOGLOBULIN-LIKE DOMAIN
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.7;300 K;Ionic strength (raw mmCIF value) 150mM;Pressure AMBIENT
NMR sample composition
1MM FLT-1(DOMAIN2) U-15N,13C; PHOSPHATE BUFFERED SALINE, PH 5.7; 50UM EDTA; 100UM NAN3; 50UM DSS
NMR sample composition
1MM FLT-1(DOMAIN2) U-15N; PHOSPHATE BUFFERED SALINE, PH 5.7; 50UM EDTA; 100UM NAN3; 50UM DSS
|
Resolution not provided |
| 1QTY VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR Deposited 1999-06-29 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain X
129–229(101 aa)
Fragment:DOMAIN 2
Chain Y
129–229(101 aa)
Fragment:DOMAIN 2
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 4000, AMMONIUMSULFATE,
TRIS , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.70 Å R-free 0.284 |
| 1QTY VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR Deposited 1999-06-29 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain T
129–229(101 aa)
Fragment:DOMAIN 2
Chain U
129–229(101 aa)
Fragment:DOMAIN 2
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 4000, AMMONIUMSULFATE,
TRIS , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.70 Å R-free 0.284 |
| 1QTY VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR Deposited 1999-06-29 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric |
Chain T
129–229(101 aa)
Fragment:DOMAIN 2
Chain U
129–229(101 aa)
Fragment:DOMAIN 2
Chain X
129–229(101 aa)
Fragment:DOMAIN 2
Chain Y
129–229(101 aa)
Fragment:DOMAIN 2
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 4000, AMMONIUMSULFATE,
TRIS , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.70 Å R-free 0.284 |
| 1RV6 Crystal Structure of PlGF in Complex with Domain 2 of VEGFR1 Deposited 2003-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain X
130–229(100 aa)
Fragment:domain-2
Chain Y
130–229(100 aa)
Fragment:domain-2
|
Not recorded | B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;pH 6.5
|
Resolution 2.45 Å R-free 0.260 |
| 2XAC Structural Insights into the Binding of VEGF-B by VEGFR-1D2: Recognition and Specificity Deposited 2010-03-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
129–226(98 aa)
Fragment:DOMAIN 2, RESIDUES 129-226
Chain X
129–226(98 aa)
Fragment:DOMAIN 2, RESIDUES 129-226
|
Not recorded | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;14% PEG 4000, 0.1M SODIUM CITRATE, PH 5.6 AND 0.2M LICL
|
Resolution 2.71 Å R-free 0.364 |
| 3HNG Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide Deposited 2009-05-31 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
801–1158(358 aa)
Fragment:KINASE DOMAIN, UNP residues 801-1158
|
Not recorded | 8ST N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide × 1 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;0.2M potassium formate, 20% PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.70 Å R-free 0.260 |
| 4CKV Crystal structure of VEGFR-1 domain 2 in presence of Zn Deposited 2014-01-09 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain X
132–225(94 aa)
Fragment:DOMAIN-2, RESIDUES 132-225
|
Not recorded | ZN ZINC ION × 2 EDO 1,2-ETHANEDIOL × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;291 K;VAPOR DIFFUSION METHOD, MOTHER LIQUOR:1MM VEGFR-1-D2,0.1%(W/V) DDM,4MM LAXAPHYCINE-A,5MM HEPES/NAOH PH 7.5. RESERVOIR:18% (W/V) PEG8000,100MM HEPES/NAOH PH 7.5, 18C
|
Resolution 2.06 Å R-free 0.205 |
| 4CL7 Crystal structure of VEGFR-1 domain 2 in presence of Cobalt Deposited 2014-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
132–225(94 aa)
Fragment:DOMAIN-2, RESIDUES 132-225
Chain C
132–225(94 aa)
Fragment:DOMAIN-2, RESIDUES 132-225
|
Not recorded | CO COBALT (II) ION × 3 EDO 1,2-ETHANEDIOL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;CRYSTAL WERE OBTAINED BY HANGING DROP METHOD FROM 1MM VEGFR1-D2, 5MM HEPES/NAOH PH7.0, 10MM COCL2, 100 MM BIS-TRIS/HCL PH6.5 15%(W/V) PEG3350.
|
Resolution 2.00 Å R-free 0.233 |
| 4CL7 Crystal structure of VEGFR-1 domain 2 in presence of Cobalt Deposited 2014-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
132–225(94 aa)
Fragment:DOMAIN-2, RESIDUES 132-225
Chain D
132–225(94 aa)
Fragment:DOMAIN-2, RESIDUES 132-225
|
Not recorded | CO COBALT (II) ION × 2 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;CRYSTAL WERE OBTAINED BY HANGING DROP METHOD FROM 1MM VEGFR1-D2, 5MM HEPES/NAOH PH7.0, 10MM COCL2, 100 MM BIS-TRIS/HCL PH6.5 15%(W/V) PEG3350.
|
Resolution 2.00 Å R-free 0.233 |
| 5ABD CRYSTAL STRUCTURE OF VEGFR-1 DOMAIN 2 IN PRESENCE OF CU Deposited 2015-08-05 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain E
132–226(95 aa)
Fragment:DOMAIN-2, RESIDUES 132-226
|
Not recorded | NA SODIUM ION × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;291 K;VAPOR DIFFUSION METHOD, MOTHER LIQUOR: 1.5MICROM VERGFR1-D2, 15MM TRIS/HCL PH 8.1, 25MM NACL, 5MM CUSO4 RESERVOIR: 19.5% (W/V) PEG8000, 100MM SA,
|
Resolution 2.00 Å R-free 0.222 |
| 5ABD CRYSTAL STRUCTURE OF VEGFR-1 DOMAIN 2 IN PRESENCE OF CU Deposited 2015-08-05 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain I
132–226(95 aa)
Fragment:DOMAIN-2, RESIDUES 132-226
|
Not recorded | CU COPPER (II) ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;291 K;VAPOR DIFFUSION METHOD, MOTHER LIQUOR: 1.5MICROM VERGFR1-D2, 15MM TRIS/HCL PH 8.1, 25MM NACL, 5MM CUSO4 RESERVOIR: 19.5% (W/V) PEG8000, 100MM SA,
|
Resolution 2.00 Å R-free 0.222 |
| 5ABD CRYSTAL STRUCTURE OF VEGFR-1 DOMAIN 2 IN PRESENCE OF CU Deposited 2015-08-05 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain X
132–226(95 aa)
Fragment:DOMAIN-2, RESIDUES 132-226
|
Not recorded | NA SODIUM ION × 1 SO4 SULFATE ION × 1 CU COPPER (II) ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;291 K;VAPOR DIFFUSION METHOD, MOTHER LIQUOR: 1.5MICROM VERGFR1-D2, 15MM TRIS/HCL PH 8.1, 25MM NACL, 5MM CUSO4 RESERVOIR: 19.5% (W/V) PEG8000, 100MM SA,
|
Resolution 2.00 Å R-free 0.222 |
| 5T89 Crystal structure of VEGF-A in complex with VEGFR-1 domains D1-6 Deposited 2016-09-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain X
27–656(630 aa)
Chain Y
27–656(630 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 19 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;293 K;10-14% PEG3000
200 mM calcium chloride
100 mM MES pH 6.5
|
Resolution 4.00 Å R-free 0.315 |
10 other PDB entries and 16 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | VGFR1_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–101; UniProt 129–229 |